Sökresultat

A new blood test demonstrated remarkable promise in discriminating between persons with and without Alzheimer’s disease and in persons at known genetic risk may be able to detect the disease as early as 20 years before the onset of cognitive impairment, according to a large international study published today in the Journal of the American Medical Association (JAMA) and simultaneously presented at

https://www.lunduniversity.lu.se/article/new-blood-test-shows-great-promise-diagnosis-alzheimers-disease - 2026-04-23

This article is over 5 years old, and the information may therefore be outdated. By studying identical twins, researchers from Lund University in Sweden have identified mechanisms that could be behind the development of type 2 diabetes. This may explain cases where one identical twin develops type 2 diabetes. The study involved 14 pairs of identical twins in Sweden and Denmark. One twin had type 2

https://www.ludc.lu.se/article/study-identical-twins-reveal-type-2-diabetes-clues - 2026-04-23

This article is over 5 years old, and the information may therefore be outdated. BEAt-DKD (“Biomarker Enterprise to Attack Diabetic Kidney Disease”), a unique public private partnership funded by the Innovative Medicines Initiative (IMI), member companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Juvenile Diabetes Research Foundation (JDRF) and the sta

https://www.ludc.lu.se/article/beat-dkd-innovative-medicines-initiative-project-precision-medicine-dkd - 2026-04-23

Researchers have identified 395 genes that are differently expressed in people with type 2 diabetes. One of the genes proved to be very strongly associated with impaired insulin secretion. Now, researchers want to investigate if it is possible to use the genetic CRISPR/Cas9 scissors to correct the gene’s activity. The research team’s scientific paper was published in the Journal of Clinical Invest

https://www.medicine.lu.se/article/pax5-gene-strongly-associated-impaired-insulin-secretion-type-2-diabetes - 2026-04-23

A research group at Lund University has studied how a molecular sensor located in the blood vessel wall, controls how the vessel compensates for high blood pressure. As we age, the sensor deteriorates, which can worsen vascular damage caused by high blood pressure and consequently lead to secondary diseases affecting the heart, brain, or other organs. In mice, the researchers demonstrate that the

https://www.medicine.lu.se/article/how-your-blood-vessels-tolerate-high-blood-pressure - 2026-04-23

With the arrival of spring, bumblebee queens take their first wing beat of the season and set out to find new nesting sites. But they are flying earlier in the year as a result of warmer climate and changing agricultural landscape, new research shows. – The risk is that we will lose additional bumblebee species and have reduced pollination of crops and wild plants, says researcher Maria Blasi Rome

https://www.cec.lu.se/article/climate-change-means-early-flight-start-risk-fewer-bumblebees-and-reduced-pollination - 2026-04-23

Three research groups at Lund University Diabetes Centre receive new project grants within precision medicine. The aim with the projects is to develop individualised treatment strategies that may benefit people with type 2 diabetes. One of the new projects will investigate whether it is possible to develop individualised treatment strategies for people with type 2 diabetes. The project EPIPREDIA i

https://www.ludc.lu.se/article/precision-medicine-research-within-type-2-diabetes-and-dementia-receives-support - 2026-04-23

This article is over 5 years old, and the information may therefore be outdated. BEAt-DKD (“Biomarker Enterprise to Attack Diabetic Kidney Disease”), a unique public private partnership funded by the Innovative Medicines Initiative (IMI), member companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Juvenile Diabetes Research Foundation (JDRF) and the sta

https://www.ludc.lu.se/article/innovative-medicines-initiative-project-precision-medicine-dkd - 2026-04-23

This article is over 5 years old, and the information may therefore be outdated. Researchers at Lund University in Sweden have found that the presence of death receptors in the blood can be used to directly measure the risk of developing cardiovascular diseases and type 2 diabetes. “We see that people with known risk factors such as high blood sugar and high blood fats also have heightened death r

https://www.ludc.lu.se/article/death-receptors-new-markers-type-2-diabetes-and-cardiovascular-disease - 2026-04-23

At the end of October 2022, the Swedish Medical Products Agency gave the go-ahead for a clinical trial of the stem cell-based therapy STEM-PD for the treatment of Parkinson’s disease. The cells, generated from embryonic stem cells, have been in development for several years and will now be transplanted into patients with Parkinson’s to replace nerve cells lost due to the disease. The clinical tria

https://www.lunduniversity.lu.se/article/nerve-cells-could-transform-treatment-parkinsons - 2026-04-23

Eating cheese and cream with a high fat content may be linked to a lower risk of developing dementia. This is shown by a new large-scale study from Lund University. The researchers analysed the dietary habits of more than 27,000 people and linked these to the occurrence of dementia over a follow-up period of up to 25 years. The debate about low-fat diets has long shaped our health advice and influ

https://www.lunduniversity.lu.se/article/full-fat-cheese-linked-lower-risk-dementia - 2026-04-23

It is time to summarise 2021, a year in which nothing was the same as before, if a year can ever be like another. For me personally, it has been transformative to take over as vice-chancellor of Lund University together with a new management team: deputy vice-chancellor Lena Eskilsson and the five pro vice-chancellors Per Mickwitz, Kristina Eneroth, Ann-Kristin Wallengren, Jimmie Kristensson and V

https://www.staff.lu.se/article/time-ring-out-old-year-and-ring-new - 2026-04-23

Thousands of people could be spared from a hip fracture each year if a new method to identify the risk of osteoporotic fractures were to be introduced in healthcare. This is the view of the researchers at Lund University in Sweden who are behind a new 3D-simulation method. The results were recently published in the Journal of Bone and Mineral Research. Osteoporosis causes 120,000 bone fractures in

https://www.lunduniversity.lu.se/article/new-method-offers-hope-fewer-fractures - 2026-04-23

Alzheimer's disease is characterized by the abnormal accumulation and spread of the tau protein in the brain. An international study can now show how tau spreads according to four distinct patterns that lead to different symptoms with different prognoses of the affected individuals. The study was published in Nature Medicine. “In contrast to how we have so far interpreted the spread of tau in the

https://www.lunduniversity.lu.se/article/alzheimers-disease-composed-four-distinct-subtypes - 2026-04-23

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information in mammograms and pinpoints with high accuracy the individual risk of metastasis in the armpit. A newly completed study shows that the model indicates that just over 40 per cent of today’s axillary surgery

https://www.medicine.lu.se/article/ai-model-lund-university-indicates-four-out-ten-breast-cancer-patients-could-avoid-axillary-surgery - 2026-04-23

Inflammatory responses in the brain have long been suspected of playing a role in Alzheimer’s disease, but are challenging to monitor in the living human brain. An international collaboration including researchers at MultiPark, Lund University has made it possible to detect elevated levels of Galectin-3, a protein expressed in the immune cells inside the brain. The results were published in Acta N

https://www.multipark.lu.se/article/biomarker-reveals-inflammatory-changes-brain-alzheimers-disease - 2026-04-23

At the end of October 2022, the Swedish Medical Products Agency gave the go-ahead for a clinical trial of the stem cell-based therapy STEM-PD for the treatment of Parkinson’s disease. The cells, generated from embryonic stem cells, have been in development for several years and will now be transplanted into patients with Parkinson’s to replace nerve cells lost due to the disease. The clinical tria

https://www.multipark.lu.se/article/nerve-cells-could-transform-treatment-parkinsons - 2026-04-23

Alzheimer's disease is characterized by the abnormal accumulation and spread of the tau protein in the brain. An international study can now show how tau spreads according to four distinct patterns that lead to different symptoms with different prognoses of the affected individuals. The study was published in Nature Medicine. “In contrast to how we have so far interpreted the spread of tau in the

https://www.multipark.lu.se/article/alzheimers-disease-composed-four-distinct-subtypes - 2026-04-23

IndiCell, short for Individualized Cell Therapy, is a national initiative in Sweden to speed up the development of advanced therapies that can help treat or cure a range of diseases and medical conditions. The project, led by researchers at the Lund Stem Cell Center at Lund University, is now celebrating its second anniversary. Launched in 2021 with funding from Vinnova, the Swedish Innovation Age

https://www.stemcellcenter.lu.se/article/innovation-environment-customised-stem-cell-treatments-turns-two - 2026-04-23

A large international study has identified three different pathways towards type 1 diabetes in children. Researchers at Lund University Diabetes Centre have contributed with data from a prospective study in southern Sweden. An important objective with the study published in Nature Communications is to gain a better understanding of how the disease develops to be able to take preventive measures. “

https://www.ludc.lu.se/article/large-international-study-points-three-pathways-towards-type-1-diabetes - 2026-04-23